Department of Defense HIV/AIDS Prevention Program
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- Dec 17, 2025
- Closes
- Sep 18, 2027 (in 384 days)
Similar opportunities open now
- High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)OpenNational Institutes of HealthCloses Mar 2027Up to $1.5M
- High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)OpenNational Institutes of HealthCloses Mar 2027
- Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Nov 2027
- Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)OpenNational Institutes of HealthCloses Nov 2027
- Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses in 26 days
Classification and identifiers
- Solicitation number
- W81XWH-22-DHAPP
- Assistance listing (CFDA)
- 12.350
Amount
Amount not published by the funder
Who can apply
About this opportunity
ATTENTION: This announcement will be revised regularly to incorporate country specific narratives (Attachment 1 of the announcement) with information vital to the content of application. Potential applicants interested in applying to this announcement should click 'Subscribe' to be notified of future revisions. DoD HIV/AID Prevention Program's (DHAPP) objective, through the PEPFAR program, is to save lives, prevent HIV infections, and accelerate progress toward achieving HIV/AIDS epidemic control and to support the development of interventions and programs in military health systems that address these issues. DHAPP works with militaries of foreign countries to devise plans based on the following process: Meet with key partners in country to determine provisional major program areas and oth...